184 related articles for article (PubMed ID: 10470293)
1. Multidrug resistance phenotype in the RMS-GR human rhabdomyosarcoma cell line obtained after polychemotherapy.
Prados J; Melguizo C; Marchal JA; Vélez C; Alvarez L; Aránega A
Jpn J Cancer Res; 1999 Jul; 90(7):788-93. PubMed ID: 10470293
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic differentiation in a human rhabdomyosarcoma cell line selected for resistance to actinomycin D.
Prados J; Melguizo C; Marchal JA; Vélez C; Alvarez L; Aránega A
Int J Cancer; 1998 Jan; 75(3):379-83. PubMed ID: 9455797
[TBL] [Abstract][Full Text] [Related]
3. Modulation of HLA class I expression in multidrug-resistant human rhabdomyosarcoma cells.
Melguizo C; Prados J; Marchal JA; Vélez C; Carrillo E; Boulaiz H; Sánchez-Montesinos I; Madeddu R; Aránega A
Neoplasma; 2003; 50(2):91-6. PubMed ID: 12740641
[TBL] [Abstract][Full Text] [Related]
4. Effects of standard chemotherapy on tumor growth and regulation of multidrug resistance genes and proteins in childhood rhabdomyosarcoma.
Seitz G; Warmann SW; Vokuhl CO; Heitmann H; Treuner C; Leuschner I; Fuchs J
Pediatr Surg Int; 2007 May; 23(5):431-9. PubMed ID: 17211591
[TBL] [Abstract][Full Text] [Related]
5. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
6. MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas.
Stein U; Shoemaker RH; Schlag PM
Eur J Cancer; 1996 Jan; 32A(1):86-92. PubMed ID: 8695249
[TBL] [Abstract][Full Text] [Related]
7. Functional expression of yeast artificial chromosome-human multidrug resistance genes in mouse cells.
Kusaba H; Kohno K; Asakuno K; Kuwano M; Okumura K; Green ED; Schlessinger D; Wada M
Genome Res; 1995 Oct; 5(3):245-58. PubMed ID: 8593612
[TBL] [Abstract][Full Text] [Related]
8. Inverse expression of mdr 1 and c-myc genes in a rhabdomyosarcoma cell line resistant to actinomycin d.
Prados J; Melguizo C; Fernández A; Aránega AE; Alvarez L; Aránega A
J Pathol; 1996 Sep; 180(1):85-9. PubMed ID: 8943821
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein U; Walther W; Shoemaker RH
J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
[TBL] [Abstract][Full Text] [Related]
10. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
Pituch-Noworolska A; Zaremba M; Wieczorek A
Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
[TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glutathione-S-transferase as a treatment strategy for multidrug resistance in childhood rhabdomyosarcoma.
Seitz G; Bonin M; Fuchs J; Poths S; Ruck P; Warmann SW; Armeanu-Ebinger S
Int J Oncol; 2010 Feb; 36(2):491-500. PubMed ID: 20043085
[TBL] [Abstract][Full Text] [Related]
13. Induction of drug resistance in embryonal rhabdomyosarcoma treated with conventional chemotherapy is associated with HLA class I increase.
Prados J; Melguizo C; Fernández JE; Carrillo E; Marchal JA; Boulaiz H; Martínez A; Rodriguez-Serrano F; Aránega A
Neoplasma; 2006; 53(3):226-31. PubMed ID: 16652192
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance and rhabdomyosarcoma (Review).
Melguizo C; Prados J; Rama AR; Ortiz R; Álvarez PJ; Fernández JE; Aranega A
Oncol Rep; 2011 Oct; 26(4):755-61. PubMed ID: 21687952
[TBL] [Abstract][Full Text] [Related]
15. Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines.
Cocker HA; Pinkerton CR; Kelland LR
Br J Cancer; 2000 Aug; 83(3):338-45. PubMed ID: 10917549
[TBL] [Abstract][Full Text] [Related]
16. Modulation of mdr1 expression by cytokines in human colon carcinoma cells: an approach for reversal of multidrug resistance.
Stein U; Walther W; Shoemaker RH
Br J Cancer; 1996 Nov; 74(9):1384-91. PubMed ID: 8912533
[TBL] [Abstract][Full Text] [Related]
17. Multidrug resistance proteins in rhabdomyosarcomas: comparison between children and adults.
Komdeur R; Klunder J; van der Graaf WT; van den Berg E; de Bont ES; Hoekstra HJ; Molenaar WM
Cancer; 2003 Apr; 97(8):1999-2005. PubMed ID: 12673730
[TBL] [Abstract][Full Text] [Related]
18. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
19. Identification of Smac mimetics as novel substrates for p-glycoprotein.
Hugle M; Czaplinski S; Habermann K; Vogler M; Fulda S
Cancer Lett; 2019 Jan; 440-441():126-134. PubMed ID: 30312727
[TBL] [Abstract][Full Text] [Related]
20. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
Tijerina M; Fowers KD; Kopecková P; Kopecek J
Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
